Victory Capital Management
PMVP icon

Victory Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Victory Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-49,330
Closed -$587K – 2680
2022
Q3 		$587K Sell
49,330
-1,180
-2% -$17K ﹤0.01% 1972
2022
Q2 		$720K Hold
50,510
– – ﹤0.01% 1902
2022
Q1 		$1.05M Sell
50,510
-981,768
-95% -$17.3M ﹤0.01% 1790
2021
Q4 		$23.8M Sell
1,032,278
-19,115
-2% -$462K 0.02% 851
2021
Q3 		$31.3M Buy
1,051,393
+132,152
+14% +$4.22M 0.03% 713
2021
Q2 		$31.4M Buy
919,241
+120,240
+15% +$4.02M 0.03% 736
2021
Q1 		$26.3M Buy
799,001
+143,292
+22% +$5.65M 0.03% 801
2020
Q4 		$40.3M Buy
655,709
+97,866
+18% +$3.84M 0.04% 593
2020
Q3 		$19.8M Buy
+557,843
New +$20.5M 0.03% 804

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Victory Capital Management's PMVP Position: Q4 2022 in Review

Victory Capital Management sold out of PMV Pharmaceuticals (PMVP) in Q4 2022, closing a stake of 49,330 shares — an estimated $587K sold.

Victory Capital Management first reported a position in PMVP in Q3 2020 and held it in 9 quarters. The position peaked at $40.3M in Q4 2020. 115 funds tracked by Wall St. Rank hold PMVP as of Q4 2022.

  • Victory Capital Management reported no remaining PMV Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 49,330 PMV Pharmaceuticals shares in Q4 2022, an estimated $587K.
  • Victory Capital Management first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 9 quarters.
  • Victory Capital Management's PMV Pharmaceuticals position peaked at $40.3M in Q4 2020.
  • 115 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.